| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZBTB20 CEBPB NRL GATA1 GATA3 HBP1 NR1D1 RFX4 MEF2A TFAP2B CIC TFDP2 HIVEP3 LHX1 USF3 VENTX CSRNP2 ZFHX4 NFIA NFATC3 NFATC4 ARNT2 TBXT DMRTA1 HES1 PAX5 NEUROG3 FOXF1 SMAD5 | 8.00e-08 | 1412 | 137 | 29 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZBTB20 CEBPB NRL GATA1 GATA3 HBP1 NR1D1 RFX4 MEF2A TFAP2B CIC TFDP2 HIVEP3 LHX1 USF3 VENTX SLC2A4RG ZFHX4 NFIA NFATC3 NFATC4 ARNT2 TBXT DMRTA1 HES1 PAX5 NEUROG3 FOXF1 SMAD5 | 1.61e-07 | 1459 | 137 | 29 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | CEBPB NRL GATA1 GATA3 RFX4 MEF2A TFAP2B TFDP2 USF3 VENTX CSRNP2 NFIA NFATC3 ARNT2 PAX5 NEUROG3 FOXF1 | 3.02e-07 | 560 | 137 | 17 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | CEBPB NRL GATA1 GATA3 RFX4 MEF2A TFAP2B TFDP2 USF3 VENTX CSRNP2 NFIA NFATC3 ARNT2 PAX5 NEUROG3 FOXF1 | 3.51e-07 | 566 | 137 | 17 | GO:0001216 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZBTB20 CEBPB NRL GATA1 GATA3 HBP1 NR1D1 RFX4 MEF2A TFAP2B HIVEP3 LHX1 VENTX SLC2A4RG ZFHX4 NFIA NFATC3 NFATC4 ARNT2 TBXT DMRTA1 HES1 PAX5 NEUROG3 FOXF1 SMAD5 | 4.61e-07 | 1271 | 137 | 26 | GO:0000987 |
| GeneOntologyMolecularFunction | transcription factor binding | SETD1A ASXL1 CEBPB GATA1 GATA3 APBB1 CAMTA2 NR1D1 MEF2A TFDP2 LATS1 NFIA NFATC3 NFATC4 ARID2 ARNT2 TBXT HES1 CRTC2 | 9.64e-07 | 753 | 137 | 19 | GO:0008134 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZBTB20 CEBPB NRL GATA1 GATA3 HBP1 NR1D1 RFX4 MEF2A TFAP2B HIVEP3 VENTX SLC2A4RG ZFHX4 NFIA NFATC3 NFATC4 ARNT2 TBXT DMRTA1 HES1 PAX5 NEUROG3 FOXF1 SMAD5 | 1.10e-06 | 1244 | 137 | 25 | GO:0000978 |
| GeneOntologyMolecularFunction | chromatin binding | ASXL1 CEBPB NRL GATA1 APBB1 CAMTA2 AHDC1 MEF2A TFAP2B CIC NFIA NFATC3 ANKRD17 HES1 NEUROG3 CRTC2 | 4.82e-05 | 739 | 137 | 16 | GO:0003682 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | ZBTB20 CEBPB GATA3 HBP1 NR1D1 NFATC3 NFATC4 HES1 NEUROG3 SMAD5 | 7.39e-05 | 320 | 137 | 10 | GO:0001227 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | ZBTB20 CEBPB GATA3 HBP1 NR1D1 NFATC3 NFATC4 HES1 NEUROG3 SMAD5 | 8.62e-05 | 326 | 137 | 10 | GO:0001217 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | SETD1A ASXL1 CEBPB GATA1 GATA3 APBB1 MEF2A LATS1 NFIA ARNT2 TBXT HES1 CRTC2 | 1.89e-04 | 582 | 137 | 13 | GO:0140297 |
| GeneOntologyMolecularFunction | phosphatase binding | 4.83e-04 | 264 | 137 | 8 | GO:0019902 | |
| GeneOntologyMolecularFunction | cytoskeletal anchor activity | 5.75e-04 | 24 | 137 | 3 | GO:0008093 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 6.16e-04 | 417 | 137 | 10 | GO:0061629 | |
| GeneOntologyMolecularFunction | E-box binding | 8.17e-04 | 61 | 137 | 4 | GO:0070888 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | DAB2IP ASXL1 CEBPB NRL GATA1 GATA3 APBB1 CAMTA2 SSBP3 NR1D1 ABLIM3 RFX4 MEF2A TFAP2B TFDP2 USF3 VENTX SLC11A1 CSRNP2 NFIA NFATC3 NFATC4 ARID2 ARNT2 RBM14 TBXT HES1 PAX5 SSBP4 NEUROG3 FOXF1 NCK2 CRTC2 SMAD5 | 1.56e-11 | 1390 | 136 | 34 | GO:0045944 |
| GeneOntologyBiologicalProcess | ureter development | 1.66e-07 | 20 | 136 | 5 | GO:0072189 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | DAB2IP ZBTB20 CEBPB GATA1 GATA3 APBB1 HBP1 NR1D1 MEF2A TFAP2B CIC TFDP2 ZNF503 LHX1 NFATC3 NFATC4 TLE7 TBXT HES1 PAX5 NEUROG3 FOXF1 NCK2 SMAD5 | 1.39e-05 | 1399 | 136 | 24 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | DAB2IP ZBTB20 CEBPB GATA1 GATA3 APBB1 HBP1 NR1D1 MEF2A TFAP2B CIC TFDP2 ZNF503 LHX1 NFATC3 NFATC4 TLE7 TBXT HES1 PAX5 NEUROG3 FOXF1 NCK2 SMAD5 | 1.64e-05 | 1413 | 136 | 24 | GO:1902679 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | DAB2IP ZBTB20 CEBPB GATA1 GATA3 APBB1 HBP1 NR1D1 MEF2A TFAP2B CIC NFATC3 NFATC4 TBXT HES1 PAX5 NEUROG3 FOXF1 NCK2 SMAD5 | 1.91e-05 | 1053 | 136 | 20 | GO:0000122 |
| GeneOntologyBiologicalProcess | ureter morphogenesis | 2.29e-05 | 9 | 136 | 3 | GO:0072197 | |
| GeneOntologyBiologicalProcess | regulation of anterior head development | 4.32e-05 | 2 | 136 | 2 | GO:2000742 | |
| GeneOntologyBiologicalProcess | positive regulation of anterior head development | 4.32e-05 | 2 | 136 | 2 | GO:2000744 | |
| GeneOntologyBiologicalProcess | kidney epithelium development | 1.01e-04 | 162 | 136 | 7 | GO:0072073 | |
| GeneOntologyBiologicalProcess | vascular associated smooth muscle cell development | 1.20e-04 | 15 | 136 | 3 | GO:0097084 | |
| GeneOntologyBiologicalProcess | tube development | DAB2IP ASXL1 UNC5B GATA3 SSBP3 SPATA2 WNK1 ADGRA2 TFAP2B CIC LHX1 NFIA NFATC3 NFATC4 ARID2 PXN TBXT HES1 GPNMB LZTS2 FOXF1 SMAD5 | 1.25e-04 | 1402 | 136 | 22 | GO:0035295 |
| GeneOntologyBiologicalProcess | nephron epithelium development | 2.07e-04 | 128 | 136 | 6 | GO:0072009 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | DAB2IP CCNJL MOK MBTPS1 TTC28 GATA3 APBB1 BIRC2 HBP1 NUP214 WNK1 TFDP2 LATS1 KIF3B ARID2 RBM14 ANKRD17 HES1 GPNMB INO80E | 2.16e-04 | 1256 | 136 | 20 | GO:0051726 |
| GeneOntologyCellularComponent | chromatin | SETD1A CEBPB NRL GATA1 GATA3 HBP1 CAMTA2 NR1D1 RFX4 MEF2A TFAP2B CIC TFDP2 LHX1 VENTX CSRNP2 ZFHX4 NFIA NFATC3 NFATC4 ARID2 ARNT2 ANKRD17 TBXT DMRTA1 HES1 PAX5 NEUROG3 FOXF1 SMAD5 INO80E | 4.67e-09 | 1480 | 136 | 31 | GO:0000785 |
| GeneOntologyCellularComponent | transcription regulator complex | CEBPB GATA1 SSBP3 MEF2A TFDP2 LHX1 NFATC3 NFATC4 ARID2 ARNT2 RBM14 TLE7 PAX5 FOXF1 SMAD5 | 8.07e-06 | 596 | 136 | 15 | GO:0005667 |
| GeneOntologyCellularComponent | actomyosin | 1.18e-04 | 117 | 136 | 6 | GO:0042641 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 6.77e-04 | 107 | 136 | 5 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 6.77e-04 | 107 | 136 | 5 | GO:0001725 | |
| MousePheno | abnormal vascular development | DOCK4 TMEM201 UNC5B GATA1 GATA3 WNK1 ADGRA2 AHDC1 TFAP2B ARID2 VCAN PXN ANKRD17 TBXT FOXF1 SMAD5 | 8.00e-06 | 542 | 114 | 16 | MP:0000259 |
| MousePheno | perinatal lethality | TCTN3 ASXL1 EYA4 ZBTB20 CEBPB ANK1 GATA1 GATA3 ADGRA2 RFX4 AHDC1 TFAP2B ZNF503 LHX1 LATS1 ZFHX4 TULP4 VCAN ARNT2 MAST1 TBXT HES1 FOXF1 | 3.45e-05 | 1130 | 114 | 23 | MP:0002081 |
| Domain | DUF1908 | 2.31e-09 | 4 | 131 | 4 | PF08926 | |
| Domain | MA_Ser/Thr_Kinase_dom | 2.31e-09 | 4 | 131 | 4 | IPR015022 | |
| Domain | MAST_pre-PK_dom | 2.31e-09 | 4 | 131 | 4 | IPR023142 | |
| Domain | - | 2.31e-09 | 4 | 131 | 4 | 1.20.1480.20 | |
| Domain | AGC-kinase_C | 4.51e-05 | 56 | 131 | 5 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 4.51e-05 | 56 | 131 | 5 | PS51285 | |
| Domain | S_TK_X | 4.51e-05 | 56 | 131 | 5 | SM00133 | |
| Domain | TIG | 6.28e-05 | 31 | 131 | 4 | PF01833 | |
| Domain | IPT | 7.14e-05 | 32 | 131 | 4 | IPR002909 | |
| Domain | ANK_REPEAT | 7.49e-05 | 253 | 131 | 9 | PS50088 | |
| Domain | ANK_REP_REGION | 7.72e-05 | 254 | 131 | 9 | PS50297 | |
| Domain | TF_GATA-2/3 | 1.46e-04 | 3 | 131 | 2 | IPR016374 | |
| Domain | SSDP_DNA-bd | 1.46e-04 | 3 | 131 | 2 | IPR008116 | |
| Domain | Pkinase_C | 2.10e-04 | 42 | 131 | 4 | PF00433 | |
| Domain | Ankyrin_rpt-contain_dom | 4.30e-04 | 254 | 131 | 8 | IPR020683 | |
| Domain | NFAT | 4.82e-04 | 5 | 131 | 2 | IPR008366 | |
| Domain | Ankyrin_rpt | 5.28e-04 | 262 | 131 | 8 | IPR002110 | |
| Domain | IPT | 8.72e-04 | 27 | 131 | 3 | SM00429 | |
| Domain | LisH | 9.72e-04 | 28 | 131 | 3 | IPR006594 | |
| Domain | LisH | 9.72e-04 | 28 | 131 | 3 | SM00667 | |
| Domain | LISH | 9.72e-04 | 28 | 131 | 3 | PS50896 | |
| Domain | UBA-like | 1.06e-03 | 64 | 131 | 4 | IPR009060 | |
| Domain | ArfGap | 1.08e-03 | 29 | 131 | 3 | SM00105 | |
| Domain | ARFGAP | 1.08e-03 | 29 | 131 | 3 | PS50115 | |
| Domain | ArfGap | 1.08e-03 | 29 | 131 | 3 | PF01412 | |
| Domain | ArfGAP | 1.08e-03 | 29 | 131 | 3 | IPR001164 | |
| Domain | Chorein_N | 1.33e-03 | 8 | 131 | 2 | PF12624 | |
| Domain | VPS13_N | 1.33e-03 | 8 | 131 | 2 | IPR026854 | |
| Domain | ZU5 | 1.70e-03 | 9 | 131 | 2 | SM00218 | |
| Domain | RFX_DNA_binding | 1.70e-03 | 9 | 131 | 2 | PF02257 | |
| Domain | DNA-bd_RFX | 1.70e-03 | 9 | 131 | 2 | IPR003150 | |
| Domain | RFX_DBD | 1.70e-03 | 9 | 131 | 2 | PS51526 | |
| Domain | - | 1.85e-03 | 248 | 131 | 7 | 1.25.40.20 | |
| Domain | ANK | 1.98e-03 | 251 | 131 | 7 | SM00248 | |
| Domain | UBA | 2.03e-03 | 36 | 131 | 3 | PF00627 | |
| Domain | RHD_dimer | 2.12e-03 | 10 | 131 | 2 | IPR032397 | |
| Domain | RHD_dimer | 2.12e-03 | 10 | 131 | 2 | PF16179 | |
| Domain | REL_1 | 2.12e-03 | 10 | 131 | 2 | PS01204 | |
| Domain | - | 2.12e-03 | 10 | 131 | 2 | 2.60.40.340 | |
| Domain | NFkB/Dor | 2.12e-03 | 10 | 131 | 2 | IPR000451 | |
| Domain | RHD_DNA_bind_dom | 2.12e-03 | 10 | 131 | 2 | IPR011539 | |
| Domain | RHD_DNA_bind | 2.12e-03 | 10 | 131 | 2 | PF00554 | |
| Domain | ZU5 | 2.12e-03 | 10 | 131 | 2 | PS51145 | |
| Domain | REL_2 | 2.12e-03 | 10 | 131 | 2 | PS50254 | |
| Domain | MAD_homology1_Dwarfin-type | 3.08e-03 | 12 | 131 | 2 | IPR003619 | |
| Domain | DWA | 3.08e-03 | 12 | 131 | 2 | SM00523 | |
| Domain | ZnF_GATA | 3.08e-03 | 12 | 131 | 2 | SM00401 | |
| Domain | ZU5 | 3.08e-03 | 12 | 131 | 2 | PF00791 | |
| Domain | ZU5_dom | 3.08e-03 | 12 | 131 | 2 | IPR000906 | |
| Domain | MH1 | 3.08e-03 | 12 | 131 | 2 | PF03165 | |
| Domain | PDZ | 3.18e-03 | 141 | 131 | 5 | PF00595 | |
| Domain | UBA | 3.62e-03 | 44 | 131 | 3 | IPR015940 | |
| Domain | Ser/Thr_kinase_AS | 3.72e-03 | 357 | 131 | 8 | IPR008271 | |
| Domain | PDZ | 3.91e-03 | 148 | 131 | 5 | SM00228 | |
| Domain | PROTEIN_KINASE_ST | 4.04e-03 | 362 | 131 | 8 | PS00108 | |
| Domain | - | 4.14e-03 | 150 | 131 | 5 | 2.30.42.10 | |
| Domain | uDENN | 4.20e-03 | 14 | 131 | 2 | SM00800 | |
| Domain | PDZ | 4.25e-03 | 151 | 131 | 5 | PS50106 | |
| Domain | UBA | 4.37e-03 | 47 | 131 | 3 | PS50030 | |
| Domain | PDZ | 4.38e-03 | 152 | 131 | 5 | IPR001478 | |
| Domain | uDENN | 4.83e-03 | 15 | 131 | 2 | PF03456 | |
| Domain | Znf_GATA | 4.83e-03 | 15 | 131 | 2 | IPR000679 | |
| Domain | GATA | 4.83e-03 | 15 | 131 | 2 | PF00320 | |
| Domain | Kinase-like_dom | 4.90e-03 | 542 | 131 | 10 | IPR011009 | |
| Domain | PROTEIN_KINASE_ATP | 5.10e-03 | 459 | 131 | 9 | PS00107 | |
| Domain | Ank | 5.46e-03 | 228 | 131 | 6 | PF00023 | |
| Domain | Pkinase | 5.48e-03 | 381 | 131 | 8 | PF00069 | |
| Domain | GATA_ZN_FINGER_1 | 5.49e-03 | 16 | 131 | 2 | PS00344 | |
| Domain | DENN | 5.49e-03 | 16 | 131 | 2 | SM00799 | |
| Domain | DENN | 5.49e-03 | 16 | 131 | 2 | PF02141 | |
| Domain | dDENN | 5.49e-03 | 16 | 131 | 2 | PF03455 | |
| Domain | GATA_ZN_FINGER_2 | 5.49e-03 | 16 | 131 | 2 | PS50114 | |
| Domain | UDENN | 5.49e-03 | 16 | 131 | 2 | PS50946 | |
| Domain | DDENN | 5.49e-03 | 16 | 131 | 2 | PS50947 | |
| Domain | dDENN | 5.49e-03 | 16 | 131 | 2 | SM00801 | |
| Domain | dDENN_dom | 5.49e-03 | 16 | 131 | 2 | IPR005112 | |
| Domain | uDENN_dom | 5.49e-03 | 16 | 131 | 2 | IPR005113 | |
| Domain | DENN | 5.49e-03 | 16 | 131 | 2 | PS50211 | |
| Domain | DENN_dom | 5.49e-03 | 16 | 131 | 2 | IPR001194 | |
| Domain | p53-like_TF_DNA-bd | 6.12e-03 | 53 | 131 | 3 | IPR008967 | |
| Domain | Ig_E-set | 6.19e-03 | 104 | 131 | 4 | IPR014756 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | CEBPB NRL GATA1 GATA3 HBP1 CAMTA2 NR1D1 RFX4 MEF2A TFAP2B CIC TFDP2 HIVEP3 USF3 VENTX ZFHX4 NFIA NFATC3 NFATC4 ARNT2 TBXT DMRTA1 HES1 PAX5 NEUROG3 FOXF1 SMAD5 | 3.43e-16 | 908 | 139 | 27 | 19274049 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DAB2IP RANBP10 SETD1A CEBPB CLASP2 NUP214 MAST2 WNK1 ADGRA2 AHDC1 CIC ZNF503 PPP1R26 HIVEP3 MST1R PRR12 SLC2A4RG GAREM2 TULP4 SEC16A NAV2 PXN SSBP4 PRRT4 NCK2 | 2.10e-12 | 1105 | 139 | 25 | 35748872 |
| Pubmed | SETD1A ASXL1 EYA4 GATA1 GATA3 R3HDM2 NUP214 SSBP3 FIGN SPATA2 MEF2A CIC TFDP2 ZNF503 PRR12 LHX1 ZFHX4 NFIA NFATC3 NFATC4 ARID2 SEC16A ANKRD17 TBXT SSBP4 SMAD5 RAVER1 INO80E | 2.60e-12 | 1429 | 139 | 28 | 35140242 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | ZBTB20 CEBPB NRL GATA1 GATA3 NR1D1 RFX4 TFAP2B LHX1 VENTX NFATC3 NFATC4 ARNT2 TBXT DMRTA1 HES1 SMAD5 | 7.40e-11 | 544 | 139 | 17 | 28473536 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DOCK4 DENND4A SORBS2 TTC28 APBB1 CLASP2 MAST2 WNK1 DENND2B CIC VPS13D LATS1 MAST4 NFATC3 SEC16A RBM14 NAV2 RAB11FIP5 ANKRD17 CRTC2 | 2.68e-10 | 861 | 139 | 20 | 36931259 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | TMEM201 CEBPB NUP214 AHDC1 CIC ZNF503 PRR12 POM121 SEC16A RBM14 TMEM209 ANKRD17 CRTC2 RAVER1 | 4.94e-09 | 457 | 139 | 14 | 32344865 |
| Pubmed | DAB2IP DOCK4 ASXL1 MBTPS1 SORBS2 TTC28 R3HDM2 NUP214 CAMTA2 SPATA2 KIF3B SEC16A MAST1 | 1.10e-08 | 407 | 139 | 13 | 12693553 | |
| Pubmed | 1.16e-08 | 152 | 139 | 9 | 38360978 | ||
| Pubmed | RANBP10 PLEKHA6 WNK1 ABLIM3 PPP1R26 HIVEP3 PRR12 VPS13D USF3 POM121 TULP4 NFIA ARID2 MAST3 | 1.28e-08 | 493 | 139 | 14 | 15368895 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | DENND4A ZBTB20 GATA1 GATA3 HBP1 SSBP3 RFX4 TFAP2B CIC TFDP2 LHX1 VENTX NFATC3 NFATC4 ARNT2 RBM14 SSBP4 SMAD5 | 1.52e-08 | 877 | 139 | 18 | 20211142 |
| Pubmed | ZBTB20 RNF44 GATA1 GATA3 NR1D1 MEF2A TFAP2B CIC LHX1 NFIA NFATC4 ARNT2 PXN TBXT PAX5 RNF111 | 2.79e-08 | 709 | 139 | 16 | 22988430 | |
| Pubmed | SETD1A RNF44 SYNPO RGP1 ADGRA2 CTTNBP2NL MAST4 NAV2 RAB11FIP5 ANKRD17 LZTS2 AGAP7P AGAP4 AGAP6 | 3.09e-08 | 529 | 139 | 14 | 14621295 | |
| Pubmed | DENND4A SORBS2 TTC28 R3HDM2 CLASP2 MAST2 WNK1 CTTNBP2NL LATS1 NFATC4 SEC16A LZTS2 CRTC2 | 3.21e-08 | 446 | 139 | 13 | 24255178 | |
| Pubmed | SYNPO NUP214 MUC12 PLEKHA6 WNK1 CIC USF3 LATS1 POM121 ARID2 NAV2 ANKRD17 RNF111 | 8.70e-08 | 486 | 139 | 13 | 20936779 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SETD1A RHBDD2 NUP214 WNK1 CIC USF3 LATS1 POM121 TULP4 NFATC4 ARID2 CRTC2 | 1.78e-07 | 430 | 139 | 12 | 35044719 |
| Pubmed | DENND4A TTC28 ATG2B CLASP2 CTTNBP2NL VPS13D MAST4 SEC16A LZTS2 | 1.80e-07 | 209 | 139 | 9 | 36779422 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | SETD1A EYA4 NUP214 AHDC1 ZNF503 PRR12 ZFHX4 NFIA ARID2 SEC16A INO80E | 1.87e-07 | 351 | 139 | 11 | 38297188 |
| Pubmed | 2.15e-07 | 104 | 139 | 7 | 9205841 | ||
| Pubmed | 2.49e-07 | 4 | 139 | 3 | 15951562 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 6.96e-07 | 180 | 139 | 8 | 35198878 | |
| Pubmed | Prethymic T-cell development defined by the expression of paired immunoglobulin-like receptors. | 9.04e-07 | 19 | 139 | 4 | 16292344 | |
| Pubmed | 9.81e-07 | 130 | 139 | 7 | 12421765 | ||
| Pubmed | TMEM201 TTC28 APBB1 POM121 SEC16A RBM14 TMEM209 RAB11FIP5 LZTS2 | 1.23e-06 | 263 | 139 | 9 | 34702444 | |
| Pubmed | ZBTB20 GATA1 GATA3 HBP1 NR1D1 MEF2A CIC TFDP2 HIVEP3 ARID2 ARNT2 PXN TBXT NEUROG3 | 4.80e-06 | 808 | 139 | 14 | 20412781 | |
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 5.16e-06 | 9 | 139 | 3 | 12640130 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DAB2IP RANBP10 TCTN3 DENND4A EYA4 ATG2B RHBDD2 CLASP2 SNX33 WNK1 POM121 KIF3B SEC16A RBM14 PXN MAST3 CRTC2 RAVER1 | 5.79e-06 | 1321 | 139 | 18 | 27173435 |
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 7.34e-06 | 10 | 139 | 3 | 20664521 | |
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | UBL7 EYA4 GATA3 NR1D1 MEF2A TFDP2 NFIA RBM14 NAV2 LZTS2 MTUS2 NCK2 RNF111 | 9.48e-06 | 742 | 139 | 13 | 26871637 |
| Pubmed | DAB2IP SORBS2 ANKS1B SYNPO ABLIM3 VCAN MAST1 AGAP7P AGAP4 AGAP6 | 9.71e-06 | 430 | 139 | 10 | 32581705 | |
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 1.01e-05 | 11 | 139 | 3 | 15381706 | |
| Pubmed | The Midbrain Preisthmus: A Poorly Known Effect of the Isthmic Organizer. | 1.31e-05 | 75 | 139 | 5 | 37298722 | |
| Pubmed | The embryonic ontogeny of the gonadal somatic cells in mice and monkeys. | 1.34e-05 | 12 | 139 | 3 | 33951437 | |
| Pubmed | 1.46e-05 | 37 | 139 | 4 | 39178848 | ||
| Pubmed | ZNF503/Zpo2 drives aggressive breast cancer progression by down-regulation of GATA3 expression. | 1.59e-05 | 2 | 139 | 2 | 28258171 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 18957548 | ||
| Pubmed | ZNF503 combined with GATA3 is a prognostic factor in triple-negative breast cancer. | 1.59e-05 | 2 | 139 | 2 | 37036735 | |
| Pubmed | Neurogenin 3 cellular and subcellular localization in the developing and adult hippocampus. | 1.59e-05 | 2 | 139 | 2 | 20235092 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 34525355 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 20110912 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 34117603 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 12767938 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 12560091 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 7749981 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 22977251 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 19362755 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 24909609 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 9576834 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 21221806 | ||
| Pubmed | 1.74e-05 | 13 | 139 | 3 | 27713690 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | SETD1A ASXL1 MBTPS1 CEBPB BIRC2 SSBP3 PPP1R26 SEC16A RBM14 TMEM209 RAB11FIP5 HES1 LZTS2 NCK2 | 2.10e-05 | 922 | 139 | 14 | 27609421 |
| Pubmed | 2.20e-05 | 14 | 139 | 3 | 22453919 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | DOCK4 TTC28 WNK1 CIC NFATC3 ARID2 SEC16A RBM14 RAB11FIP5 LZTS2 NCK2 | 2.61e-05 | 588 | 139 | 11 | 38580884 |
| Pubmed | 2.69e-05 | 87 | 139 | 5 | 12465718 | ||
| Pubmed | Widespread macromolecular interaction perturbations in human genetic disorders. | UBL7 LURAP1 SORBS2 GATA1 GATA3 BIRC2 NAV2 LZTS2 MTUS2 NEUROG3 NCK2 | 2.69e-05 | 590 | 139 | 11 | 25910212 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MBTPS1 ZBTB20 SYNPO CLASP2 SSBP3 DENND2B AHDC1 MEF2A HIVEP3 USF3 TULP4 NFIA MAST1 ANKRD17 LZTS2 RPS6KL1 NCK2 RAVER1 | 2.87e-05 | 1489 | 139 | 18 | 28611215 |
| Pubmed | 3.35e-05 | 91 | 139 | 5 | 21194568 | ||
| Pubmed | 3.37e-05 | 16 | 139 | 3 | 12787506 | ||
| Pubmed | Gata6 is an important regulator of mouse pancreas development. | 3.37e-05 | 16 | 139 | 3 | 16887115 | |
| Pubmed | 3.37e-05 | 16 | 139 | 3 | 33454424 | ||
| Pubmed | APBB1 HBP1 R3HDM2 WNK1 AHDC1 CIC POM121 ARNT2 RBM14 LZTS2 NCK2 | 3.54e-05 | 608 | 139 | 11 | 16713569 | |
| Pubmed | 3.58e-05 | 225 | 139 | 7 | 12168954 | ||
| Pubmed | DAB2IP EYA4 PLEKHA6 WNK1 CTTNBP2NL SEC16A RBM14 NAV2 PXN RAVER1 | 3.70e-05 | 503 | 139 | 10 | 16964243 | |
| Pubmed | TMEM201 DENND4A ATG2B APBB1 RHBDD2 RGP1 VPS13D SEC16A TMEM209 RAB11FIP5 | 3.76e-05 | 504 | 139 | 10 | 34432599 | |
| Pubmed | 4.11e-05 | 230 | 139 | 7 | 35449600 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 12041667 | ||
| Pubmed | The Rip11/Rab11-FIP5 and kinesin II complex regulates endocytic protein recycling. | 4.75e-05 | 3 | 139 | 2 | 18957512 | |
| Pubmed | Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer. | 4.75e-05 | 3 | 139 | 2 | 22101766 | |
| Pubmed | GATA-1, -2 and -3 genes expression in bone marrow microenviroment with chronic aplastic anemia. | 4.75e-05 | 3 | 139 | 2 | 17654061 | |
| Pubmed | NFATc3 and NFATc4 are required for cardiac development and mitochondrial function. | 4.75e-05 | 3 | 139 | 2 | 12750314 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 34354706 | ||
| Pubmed | Expression patterns of PAX5, c-Met, and paxillin in neuroendocrine tumors of the lung. | 4.75e-05 | 3 | 139 | 2 | 21043826 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 16287482 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 26770020 | ||
| Pubmed | Kindlin supports platelet integrin αIIbβ3 activation by interacting with paxillin. | 4.75e-05 | 3 | 139 | 2 | 28954813 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 25422138 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 29030964 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 15563463 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 23407945 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 12079286 | ||
| Pubmed | Dynamic regulation of Gata factor levels is more important than their identity. | 4.75e-05 | 3 | 139 | 2 | 17327407 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 22778136 | ||
| Pubmed | Zbtb20 promotes astrocytogenesis during neocortical development. | 4.75e-05 | 3 | 139 | 2 | 27000654 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 14630949 | ||
| Pubmed | Calcineurin signaling regulates neural induction through antagonizing the BMP pathway. | 4.88e-05 | 18 | 139 | 3 | 24698271 | |
| Pubmed | 4.88e-05 | 18 | 139 | 3 | 15870281 | ||
| Pubmed | 4.97e-05 | 418 | 139 | 9 | 34709266 | ||
| Pubmed | 5.52e-05 | 101 | 139 | 5 | 9872452 | ||
| Pubmed | A multistate stem cell dynamics maintains homeostasis in mouse spermatogenesis. | 5.78e-05 | 19 | 139 | 3 | 34686326 | |
| Pubmed | 5.78e-05 | 19 | 139 | 3 | 30449657 | ||
| Pubmed | 6.78e-05 | 20 | 139 | 3 | 37073980 | ||
| Pubmed | 6.78e-05 | 20 | 139 | 3 | 29412136 | ||
| Pubmed | 6.78e-05 | 20 | 139 | 3 | 16943278 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SORBS2 NUP214 SNX33 NR1D1 CTTNBP2NL CIC LATS1 NFIA SEC16A RBM14 ANKRD17 RAVER1 | 6.87e-05 | 774 | 139 | 12 | 15302935 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | DAB2IP FERMT1 CLASP2 PLEKHA6 SPATA2 WNK1 MEF2A NFIA SEC16A PXN RAB11FIP5 LZTS2 CRTC2 SMAD5 | 7.53e-05 | 1038 | 139 | 14 | 26673895 |
| Pubmed | Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks. | 8.66e-05 | 111 | 139 | 5 | 22558309 | |
| Pubmed | 9.09e-05 | 261 | 139 | 7 | 33277362 | ||
| Pubmed | Conserved and Divergent Molecular and Anatomic Features of Human and Mouse Nephron Patterning. | 9.10e-05 | 22 | 139 | 3 | 29449451 | |
| Pubmed | 9.47e-05 | 4 | 139 | 2 | 25918731 | ||
| Pubmed | 9.47e-05 | 4 | 139 | 2 | 19586940 | ||
| Pubmed | 9.47e-05 | 4 | 139 | 2 | 9660947 | ||
| Interaction | YWHAH interactions | DAB2IP DOCK4 DENND4A SORBS2 CEBPB TTC28 NHSL2 APBB1 R3HDM2 CLASP2 SNX33 MAST2 WNK1 DENND2B CIC MST1R VPS13D LATS1 GRID2IP MAST4 NFATC3 SEC16A RBM14 NAV2 MAST1 RAB11FIP5 ANKRD17 USP4 MAST3 CRTC2 | 5.03e-11 | 1102 | 137 | 30 | int:YWHAH |
| Interaction | TLE3 interactions | CEBPB GATA1 GATA3 FIGN AHDC1 CIC ZNF503 PRR12 VENTX POM121 NFIA ARID2 RBM14 TBXT SSBP4 CRTC2 RAVER1 | 7.71e-10 | 376 | 137 | 17 | int:TLE3 |
| Interaction | YWHAB interactions | DAB2IP DOCK4 DENND4A SORBS2 CEBPB TTC28 R3HDM2 CLASP2 MAST2 WNK1 DENND2B CIC MST1R VPS13D LATS1 GRID2IP MAST4 NFATC3 RBM14 NAV2 MAST1 RAB11FIP5 ANKRD17 USP4 HES1 MAST3 CRTC2 | 8.97e-10 | 1014 | 137 | 27 | int:YWHAB |
| Interaction | YWHAG interactions | DAB2IP DOCK4 DENND4A SORBS2 CEBPB TTC28 NHSL2 APBB1 R3HDM2 SYNPO CLASP2 SNX33 MAST2 WNK1 DENND2B CIC MST1R VPS13D LATS1 GRID2IP MAST4 NFATC3 SEC16A RBM14 NAV2 RAB11FIP5 ANKRD17 LZTS2 MAST3 CRTC2 | 1.00e-09 | 1248 | 137 | 30 | int:YWHAG |
| Interaction | YWHAZ interactions | DAB2IP ASXL1 DENND4A SORBS2 CEBPB TTC28 R3HDM2 SYNPO CLASP2 SNX33 SPATA2 MAST2 WNK1 DENND2B CIC MST1R VPS13D LATS1 MAST4 NFATC3 NFATC4 RBM14 NAV2 MAST1 RAB11FIP5 ANKRD17 MAST3 CRTC2 | 5.83e-08 | 1319 | 137 | 28 | int:YWHAZ |
| Interaction | TBR1 interactions | 7.81e-08 | 113 | 137 | 9 | int:TBR1 | |
| Interaction | BCL9 interactions | 1.26e-07 | 86 | 137 | 8 | int:BCL9 | |
| Interaction | NUP35 interactions | TMEM201 CEBPB NUP214 AHDC1 CIC ZNF503 HIVEP3 PRR12 POM121 SEC16A RBM14 TMEM209 ANKRD17 CRTC2 RAVER1 | 2.05e-07 | 424 | 137 | 15 | int:NUP35 |
| Interaction | TOP3B interactions | DAB2IP RANBP10 SETD1A CEBPB R3HDM2 CLASP2 NUP214 MAST2 WNK1 ADGRA2 AHDC1 CIC ZNF503 PPP1R26 HIVEP3 MST1R PRR12 SLC2A4RG GAREM2 TULP4 SEC16A RBM14 NAV2 PXN ANKRD17 SSBP4 PRRT4 NCK2 | 5.41e-07 | 1470 | 137 | 28 | int:TOP3B |
| Interaction | CREBBP interactions | SETD1A EYA4 CEBPB GATA1 GATA3 ANKS1B HBP1 CLASP2 TFAP2B LATS1 NFIA NFATC4 ARNT2 TBXT HES1 PAX5 RNF111 | 6.78e-07 | 599 | 137 | 17 | int:CREBBP |
| Interaction | SSBP3 interactions | 1.55e-06 | 119 | 137 | 8 | int:SSBP3 | |
| Interaction | IRF4 interactions | 1.83e-06 | 85 | 137 | 7 | int:IRF4 | |
| Interaction | LZTS2 interactions | SORBS2 TTC28 GATA1 CCDC187 R3HDM2 SYNPO SPATA2 LATS1 ARNT2 SEC16A MAST1 RAB11FIP5 LZTS2 NCK2 RAVER1 | 2.18e-06 | 512 | 137 | 15 | int:LZTS2 |
| Interaction | DTX2 interactions | EYA4 CEBPB ZNF503 PRR12 NFIA ARNT2 SEC16A RBM14 TMEM209 PAX5 CRTC2 RAVER1 | 2.72e-06 | 330 | 137 | 12 | int:DTX2 |
| Interaction | YWHAE interactions | DAB2IP DENND4A SORBS2 CEBPB TTC28 R3HDM2 CLASP2 SNX33 SPATA2 MAST2 WNK1 DENND2B CIC TFDP2 MST1R LATS1 MAST4 RBM14 NAV2 MAST1 RAB11FIP5 ANKRD17 MAST3 CRTC2 | 3.81e-06 | 1256 | 137 | 24 | int:YWHAE |
| Interaction | TNRC6C interactions | 4.69e-06 | 138 | 137 | 8 | int:TNRC6C | |
| Interaction | SFN interactions | SETD1A DENND4A SORBS2 CEBPB CLASP2 MAST2 WNK1 DENND2B MST1R LATS1 MAST4 NFIA NFATC3 RBM14 NAV2 ANKRD17 USP4 | 4.77e-06 | 692 | 137 | 17 | int:SFN |
| Interaction | GATA2 interactions | 8.98e-06 | 199 | 137 | 9 | int:GATA2 | |
| Interaction | LMO3 interactions | 9.57e-06 | 152 | 137 | 8 | int:LMO3 | |
| Interaction | LDB1 interactions | 1.37e-05 | 115 | 137 | 7 | int:LDB1 | |
| Interaction | SIX4 interactions | 1.48e-05 | 46 | 137 | 5 | int:SIX4 | |
| Interaction | YWHAQ interactions | DAB2IP DENND4A SORBS2 CEBPB TTC28 R3HDM2 CLASP2 MAST2 WNK1 DENND2B CIC MST1R VPS13D LATS1 MAST4 NFATC3 NFATC4 RBM14 NAV2 ANKRD17 CRTC2 | 2.15e-05 | 1118 | 137 | 21 | int:YWHAQ |
| Interaction | PAX7 interactions | 2.23e-05 | 124 | 137 | 7 | int:PAX7 | |
| Interaction | MAST4 interactions | 2.72e-05 | 26 | 137 | 4 | int:MAST4 | |
| Interaction | TEAD1 interactions | 2.77e-05 | 176 | 137 | 8 | int:TEAD1 | |
| Interaction | PAX9 interactions | 3.03e-05 | 130 | 137 | 7 | int:PAX9 | |
| Interaction | LHX3 interactions | 3.95e-05 | 185 | 137 | 8 | int:LHX3 | |
| Interaction | GATA3 interactions | 4.27e-05 | 187 | 137 | 8 | int:GATA3 | |
| Interaction | EYA4 interactions | 4.36e-05 | 243 | 137 | 9 | int:EYA4 | |
| Interaction | SP7 interactions | 4.46e-05 | 304 | 137 | 10 | int:SP7 | |
| Interaction | IRF8 interactions | 4.63e-05 | 58 | 137 | 5 | int:IRF8 | |
| Interaction | LHX6 interactions | 4.63e-05 | 58 | 137 | 5 | int:LHX6 | |
| Interaction | DPF1 interactions | 4.68e-05 | 95 | 137 | 6 | int:DPF1 | |
| Interaction | SSBP4 interactions | 5.03e-05 | 59 | 137 | 5 | int:SSBP4 | |
| Interaction | NFIB interactions | 5.33e-05 | 142 | 137 | 7 | int:NFIB | |
| Interaction | TRPS1 interactions | 5.58e-05 | 143 | 137 | 7 | int:TRPS1 | |
| Interaction | TRAF2 interactions | DAB2IP CCNJL NHSL2 BIRC2 CCDC187 SPATA2 MAST2 HIVEP3 LATS1 POM121 ARNT2 SEC16A USP4 LZTS2 | 6.39e-05 | 603 | 137 | 14 | int:TRAF2 |
| Interaction | CHD7 interactions | 7.54e-05 | 150 | 137 | 7 | int:CHD7 | |
| Interaction | FEV interactions | 7.61e-05 | 203 | 137 | 8 | int:FEV | |
| Interaction | CGN interactions | 8.20e-05 | 152 | 137 | 7 | int:CGN | |
| Interaction | NCOR2 interactions | 8.26e-05 | 264 | 137 | 9 | int:NCOR2 | |
| Interaction | SATB2 interactions | 1.09e-04 | 159 | 137 | 7 | int:SATB2 | |
| Interaction | PAX8 interactions | 1.12e-04 | 111 | 137 | 6 | int:PAX8 | |
| Interaction | KDM6A interactions | 1.22e-04 | 162 | 137 | 7 | int:KDM6A | |
| Interaction | TNRC6A interactions | 1.29e-04 | 280 | 137 | 9 | int:TNRC6A | |
| Interaction | BCL7C interactions | 1.36e-04 | 115 | 137 | 6 | int:BCL7C | |
| Interaction | ZFHX4 interactions | 1.40e-04 | 73 | 137 | 5 | int:ZFHX4 | |
| Interaction | TBXT interactions | 1.42e-04 | 116 | 137 | 6 | int:TBXT | |
| Interaction | GARRE1 interactions | 1.48e-04 | 167 | 137 | 7 | int:GARRE1 | |
| Interaction | ELMO1 interactions | 1.54e-04 | 40 | 137 | 4 | int:ELMO1 | |
| Interaction | NFATC4 interactions | 1.54e-04 | 40 | 137 | 4 | int:NFATC4 | |
| Interaction | PUM1 interactions | 1.55e-04 | 287 | 137 | 9 | int:PUM1 | |
| Interaction | KMT2D interactions | 1.59e-04 | 169 | 137 | 7 | int:KMT2D | |
| Interaction | C2CD6 interactions | 1.59e-04 | 75 | 137 | 5 | int:C2CD6 | |
| Interaction | EGR2 interactions | 1.71e-04 | 171 | 137 | 7 | int:EGR2 | |
| Interaction | TLX3 interactions | 1.72e-04 | 291 | 137 | 9 | int:TLX3 | |
| Interaction | BCL7A interactions | 1.96e-04 | 123 | 137 | 6 | int:BCL7A | |
| Interaction | TLX1 interactions | 1.97e-04 | 175 | 137 | 7 | int:TLX1 | |
| Interaction | FUBP3 interactions | 2.01e-04 | 297 | 137 | 9 | int:FUBP3 | |
| Interaction | ARID1B interactions | 2.11e-04 | 177 | 137 | 7 | int:ARID1B | |
| Interaction | RUNX2 interactions | 2.23e-04 | 126 | 137 | 6 | int:RUNX2 | |
| Interaction | TLE5 interactions | CCNJL EYA4 GATA1 GATA3 ZNF503 VENTX NFIA TBXT LZTS2 MTUS2 INO80E | 2.26e-04 | 443 | 137 | 11 | int:TLE5 |
| Interaction | SOX7 interactions | 2.42e-04 | 82 | 137 | 5 | int:SOX7 | |
| Interaction | LMO2 interactions | 2.75e-04 | 310 | 137 | 9 | int:LMO2 | |
| Interaction | ZNF644 interactions | 2.86e-04 | 186 | 137 | 7 | int:ZNF644 | |
| Interaction | CCAR1 interactions | 2.95e-04 | 187 | 137 | 7 | int:CCAR1 | |
| Interaction | MYB interactions | 2.99e-04 | 133 | 137 | 6 | int:MYB | |
| Interaction | STXBP4 interactions | 3.02e-04 | 86 | 137 | 5 | int:STXBP4 | |
| Interaction | GSC interactions | 3.19e-04 | 87 | 137 | 5 | int:GSC | |
| Interaction | LHX9 interactions | 3.22e-04 | 20 | 137 | 3 | int:LHX9 | |
| Interaction | GSK3A interactions | DENND4A TTC28 ATG2B CLASP2 AHDC1 CTTNBP2NL VPS13D MAST4 SEC16A PXN LZTS2 | 3.36e-04 | 464 | 137 | 11 | int:GSK3A |
| Interaction | PRR12 interactions | 3.36e-04 | 88 | 137 | 5 | int:PRR12 | |
| Interaction | SYNPO interactions | 3.46e-04 | 192 | 137 | 7 | int:SYNPO | |
| Interaction | HELZ interactions | 3.81e-04 | 257 | 137 | 8 | int:HELZ | |
| Interaction | RPS6KL1 interactions | 3.99e-04 | 51 | 137 | 4 | int:RPS6KL1 | |
| Interaction | SOX15 interactions | 4.09e-04 | 141 | 137 | 6 | int:SOX15 | |
| Interaction | HES6 interactions | 4.30e-04 | 52 | 137 | 4 | int:HES6 | |
| Interaction | NCK2 interactions | 4.33e-04 | 262 | 137 | 8 | int:NCK2 | |
| Interaction | PUM2 interactions | 4.57e-04 | 144 | 137 | 6 | int:PUM2 | |
| Interaction | MPHOSPH9 interactions | 4.79e-04 | 95 | 137 | 5 | int:MPHOSPH9 | |
| Interaction | LDB2 interactions | 5.71e-04 | 56 | 137 | 4 | int:LDB2 | |
| Interaction | NFIC interactions | 5.92e-04 | 210 | 137 | 7 | int:NFIC | |
| Interaction | ZNF503 interactions | 6.11e-04 | 57 | 137 | 4 | int:ZNF503 | |
| GeneFamily | Nuclear factors of activated T-cells | 2.54e-04 | 5 | 92 | 2 | 665 | |
| GeneFamily | ArfGAPs | 6.23e-04 | 33 | 92 | 3 | 395 | |
| GeneFamily | PDZ domain containing | 1.07e-03 | 152 | 92 | 5 | 1220 | |
| GeneFamily | Ankyrin repeat domain containing | 1.48e-03 | 242 | 92 | 6 | 403 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.58e-03 | 15 | 92 | 2 | 82 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 3.31e-03 | 17 | 92 | 2 | 1291 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.04e-03 | 206 | 92 | 5 | 682 | |
| GeneFamily | RNA binding motif containing | 4.65e-03 | 213 | 92 | 5 | 725 | |
| GeneFamily | CD molecules|Mucins | 5.05e-03 | 21 | 92 | 2 | 648 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | DOCK4 CELF5 ANK1 GATA3 ANKS1B PLEKHA6 SSBP3 ABLIM3 AHDC1 HIVEP3 LHX1 MAST4 ZFHX4 TULP4 VCAN ARNT2 MAST1 PAX5 MTUS2 PRRT4 | 1.45e-06 | 1106 | 138 | 20 | M39071 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | DOCK4 CELF5 EYA4 ANK1 GATA3 PLEKHA6 SSBP3 ABLIM3 AHDC1 TFAP2B KIF3B ZFHX4 TULP4 MAST1 PAX5 | 4.75e-06 | 703 | 138 | 15 | M39070 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | CELF5 GATA3 ANKS1B PLEKHA6 SSBP3 ABLIM3 HIVEP3 LHX1 ZFHX4 MAST1 PAX5 MTUS2 | 6.83e-06 | 465 | 138 | 12 | M39066 |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN | 1.10e-05 | 199 | 138 | 8 | M9443 | |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_DN | 1.14e-05 | 200 | 138 | 8 | M9311 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MOK DOCK4 ASXL1 ZBTB20 TTC28 TRPC1 R3HDM2 CLASP2 MAST2 ABLIM3 DENND2B AHDC1 MEF2A NFATC3 ARNT2 ANKRD17 | 1.19e-05 | 856 | 138 | 16 | M4500 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | DOCK4 CELF5 ANK1 CLASP2 PLEKHA6 MAST2 ABLIM3 HIVEP3 ZFHX4 TULP4 MAST1 MTUS2 PRRT4 | 1.36e-05 | 584 | 138 | 13 | M39068 |
| Coexpression | MANALO_HYPOXIA_UP | 1.36e-05 | 205 | 138 | 8 | M259 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | ASXL1 RHBDD2 BIRC2 WNK1 RFX4 TFAP2B TFDP2 VCAN RBM14 HES1 CD96 NEUROG3 | 2.32e-05 | 526 | 138 | 12 | M2520 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 2.33e-05 | 221 | 138 | 8 | M39222 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | DAB2IP EYA4 SORBS2 TTC28 NHSL2 UNC5B GATA3 ADGRA2 DENND2B NAV2 FOXF1 | 6.28e-05 | 493 | 138 | 11 | M19391 |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | ASXL1 RHBDD2 BIRC2 WNK1 RFX4 TFAP2B TFDP2 VCAN RBM14 HES1 CD96 NEUROG3 | 6.37e-05 | 584 | 138 | 12 | MM1080 |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_DN | 7.57e-05 | 133 | 138 | 6 | M8880 | |
| Coexpression | FAN_EMBRYONIC_CTX_EX_2_EXCITATORY_NEURON | 7.61e-05 | 16 | 138 | 3 | M39025 | |
| Coexpression | DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP | CLASP2 TFAP2B CSRNP2 TULP4 ANKRD17 PAX5 DNASE1L1 FOXF1 RNF111 | 8.28e-05 | 340 | 138 | 9 | M2012 |
| Coexpression | PHONG_TNF_RESPONSE_NOT_VIA_P38 | 8.46e-05 | 341 | 138 | 9 | M2504 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 8.92e-05 | 137 | 138 | 6 | M39241 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_DN | 8.92e-05 | 137 | 138 | 6 | MM990 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 9.16e-05 | 199 | 138 | 7 | M5893 | |
| Coexpression | GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_UP | 9.45e-05 | 200 | 138 | 7 | M9860 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_2H_BMDC_DN | 9.45e-05 | 200 | 138 | 7 | M3939 | |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN | 9.66e-05 | 139 | 138 | 6 | M8948 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | MBTPS1 EYA4 TTC28 GATA3 CLASP2 NUP214 MSI1 ADGRA2 CTTNBP2NL LATS1 CSRNP2 ZFHX4 NFIA NFATC4 VCAN ARNT2 RBM14 TBXT FOXF1 SMAD5 | 1.66e-07 | 806 | 134 | 20 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | EYA4 TTC28 GATA3 NUP214 CTTNBP2NL LATS1 ZFHX4 NFIA NFATC4 VCAN ARNT2 FOXF1 SMAD5 | 1.89e-06 | 407 | 134 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 4.81e-06 | 149 | 134 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500 | 2.14e-05 | 89 | 134 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | MBTPS1 EYA4 TTC28 CLASP2 NUP214 WNK1 TULP4 NFIA VCAN ARNT2 SMAD5 | 3.39e-05 | 385 | 134 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | CCNJL EYA4 ZBTB20 ANK1 FERMT1 GATA3 SYNPO MSI1 FIGN TFAP2B PPP1R26 HIVEP3 ZFHX4 NFIA RAB11FIP5 SSBP4 DNASE1L1 MTUS2 | 3.80e-05 | 967 | 134 | 18 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | CELF5 ZBTB20 TTC28 UNC5B FERMT1 GATA3 SYNPO TFAP2B HIVEP3 VPS13D ZFHX4 TULP4 NFIA ARNT2 RAB11FIP5 SSBP4 PRRT4 FOXF1 | 4.11e-05 | 973 | 134 | 18 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | 5.56e-05 | 209 | 134 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | UBL7 CCNJL NHSL2 HBP1 SSBP3 FIGN MAST2 RFX4 AHDC1 CTTNBP2NL TFAP2B ZNF503 LHX1 ZFHX4 PXN RAVER1 | 8.45e-05 | 843 | 134 | 16 | gudmap_developingGonad_e11.5_testes_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_500 | 8.65e-05 | 165 | 134 | 7 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_200 | 1.25e-04 | 175 | 134 | 7 | gudmap_kidney_P4_CapMesRenVes_Crym_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.41e-04 | 42 | 134 | 4 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | DAB2IP SETD1A SORBS2 ZBTB20 NHSL2 MSI1 SSBP3 MEF2A LHX1 VPS13D MAST4 PLAA TULP4 NFIA NAV2 | 1.42e-04 | 790 | 134 | 15 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | MOK EYA4 ANK1 TTC28 GATA3 BIRC2 SYNPO SNX33 CTTNBP2NL TFAP2B CIC PPIF USF3 LATS1 ZFHX4 NFIA SMAD5 | 1.58e-04 | 985 | 134 | 17 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.67e-04 | 312 | 134 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_100 | 1.92e-04 | 84 | 134 | 5 | gudmap_kidney_P2_CapMes_Crym_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | MBTPS1 EYA4 TTC28 GATA3 CLASP2 NUP214 MSI1 WNK1 ZFHX4 TULP4 NFIA VCAN ARNT2 FOXF1 SMAD5 | 2.07e-04 | 818 | 134 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | 2.22e-04 | 398 | 134 | 10 | gudmap_kidney_P4_CapMesRenVes_Crym_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | DOCK4 DENND4A SORBS2 MUC16 WNK1 DENND2B TFDP2 ZFHX4 NFIA VCAN NAV2 DMRTA1 HES1 SMAD5 | 2.48e-04 | 740 | 134 | 14 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_100 | 2.52e-04 | 89 | 134 | 5 | gudmap_kidney_P3_CapMes_Crym_100 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.52e-04 | 89 | 134 | 5 | gudmap_developingGonad_e11.5_testes_k1_1000 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_200 | 2.55e-04 | 139 | 134 | 6 | gudmap_kidney_P2_CapMes_Crym_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#2_top-relative-expression-ranked_200 | 2.59e-04 | 20 | 134 | 3 | gudmap_developingGonad_e11.5_testes_k2_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | 3.15e-04 | 416 | 134 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 3.47e-04 | 22 | 134 | 3 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | CELF5 SORBS2 SYNPO CLASP2 NUP214 SSBP3 CTTNBP2NL TFAP2B ZFHX4 NFIA NFATC4 VCAN RBM14 SMAD5 | 3.66e-04 | 769 | 134 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.70e-04 | 209 | 134 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000 | EYA4 ZBTB20 ANK1 FERMT1 SYNPO TFAP2B PPP1R26 HIVEP3 ZFHX4 NFIA MAST1 RAB11FIP5 DMRTA1 DNASE1L1 MTUS2 FOXF1 | 4.03e-04 | 968 | 134 | 16 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#1_top-relative-expression-ranked_500 | 4.13e-04 | 99 | 134 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k1_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | CCNJL EYA4 SORBS2 FERMT1 SYNPO MSI1 FIGN RFX4 TFAP2B HIVEP3 ZFHX4 NFIA NAV2 MAST1 RAB11FIP5 DMRTA1 | 4.27e-04 | 973 | 134 | 16 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | DOCK4 SETD1A SORBS2 ZBTB20 TTYH2 GATA1 MSI1 SSBP3 MEF2A MAST4 NFIA NAV2 ANKRD17 DMRTA1 | 5.09e-04 | 795 | 134 | 14 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.45e-04 | 223 | 134 | 7 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | DAB2IP SETD1A ZBTB20 NHSL2 UNC5B MSI1 SSBP3 HIVEP3 LHX1 MAST4 PLAA TULP4 NFIA NAV2 | 5.48e-04 | 801 | 134 | 14 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#1_top-relative-expression-ranked_500 | 5.99e-04 | 61 | 134 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_k1_500 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_100 | 6.37e-04 | 62 | 134 | 4 | gudmap_kidney_P1_CapMes_Crym_100 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.54e-04 | 230 | 134 | 7 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.62e-04 | 301 | 134 | 8 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_1000 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.80e-07 | 194 | 139 | 8 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-OPC_related-Oligodendrocyte/OPC|3m / Sample Type, Dataset, Time_group, and Cell type. | 2.27e-07 | 200 | 139 | 8 | 7557ea33c3d080d0fa4ca0c2703279932d01e6d0 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-OPC_related|3m / Sample Type, Dataset, Time_group, and Cell type. | 2.27e-07 | 200 | 139 | 8 | 3dcaeb9f1e387784c299bfe0da1516598f82edf5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.13e-06 | 188 | 139 | 7 | 9db3d3010cb8a1f3ee1cdccaf3cbaac3cf983fc5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.13e-06 | 188 | 139 | 7 | 72be6fe654f3a5f654d3b9680145bce7ae9b721d | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-Treg|COVID-19_Mild / Disease group, lineage and cell class | 2.13e-06 | 188 | 139 | 7 | 42553fdc127e5f613ffd5067620a768a40f1a8a1 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-IPC_like|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.62e-06 | 194 | 139 | 7 | 3e90be6f5b1c5c83632e62941fb18d6a627ec1b5 | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega|Control_saline / Treatment groups by lineage, cell group, cell type | 3.00e-06 | 198 | 139 | 7 | 1a39a98beef68e1e6d3adc25270a3336fcc5baf4 | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|Control_saline / Treatment groups by lineage, cell group, cell type | 3.00e-06 | 198 | 139 | 7 | dd80fd9671ee863aebcf4c1023d3e004cc2ee709 | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary|Control_saline / Treatment groups by lineage, cell group, cell type | 3.00e-06 | 198 | 139 | 7 | cfc2a860bae883299987d3e374d0476ca20e1bdd | |
| ToppCell | mild-Treg|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.00e-06 | 198 | 139 | 7 | 0269617c0628003d2a13dab98abfd2d15775d16a | |
| ToppCell | BAL-Severe-cDC_0|Severe / Compartment, Disease Groups and Clusters | 3.10e-06 | 199 | 139 | 7 | d39be8b173156bf87baddd3caed4b35597c53ea1 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-OPC_related-Oligodendrocyte/OPC|2m / Sample Type, Dataset, Time_group, and Cell type. | 3.21e-06 | 200 | 139 | 7 | 3c9a2f02294a9fb892b89e856291bd6423ffa0a9 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-OPC_related|2m / Sample Type, Dataset, Time_group, and Cell type. | 3.21e-06 | 200 | 139 | 7 | 8e49e7e9b02d8411e4ffae1f5113a2c18f5bf179 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.21e-06 | 200 | 139 | 7 | f100edfd2b3b742458cbbf34de9c403c4d272d3c | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-Treg|COVID-19_Mild / Disease, condition lineage and cell class | 3.21e-06 | 200 | 139 | 7 | c6ae15f7deba26008af5b647855675003bb2ebcd | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 3.21e-06 | 200 | 139 | 7 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.21e-06 | 200 | 139 | 7 | fa1eaf008b54bdf7bbcdec8134460c5f64490de9 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 161 | 139 | 6 | 3f3a2148c8d65e6a06f8d8116a3aa58dda17d618 | |
| ToppCell | Control-MAIT|World / Disease group and Cell class | 1.24e-05 | 163 | 139 | 6 | 0ca4b835936b4f82217cbe57210c1dd90986c1d0 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 164 | 139 | 6 | b895674ed2df87db8fbfb30b7e31620945588491 | |
| ToppCell | mild_COVID-19-Treg|World / disease group, cell group and cell class (v2) | 1.43e-05 | 167 | 139 | 6 | 69330689b6e353c8ee9ea1b63a5eac6ab38d456f | |
| ToppCell | Control-Hematopoietic_Meg-Ery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.53e-05 | 169 | 139 | 6 | c2e2a7b89fe4a64d79efafdec037c4104f433061 | |
| ToppCell | Control-Hematopoietic_Meg-Ery-Erythroid|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.53e-05 | 169 | 139 | 6 | df1fc1477bbbb285063b9b122b1ac84c87fd7fa8 | |
| ToppCell | Control-Hematopoietic_Meg-Ery-Erythroid-Erythroid|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.53e-05 | 169 | 139 | 6 | 92986559aa4a744e8b0487b0ae035cfb1fbf9890 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.63e-05 | 171 | 139 | 6 | 82de2885c8ce4fb7776da6a0207b3355c0910121 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.63e-05 | 171 | 139 | 6 | 09e653973962fb884878089d281f0947f7a285f6 | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-05 | 177 | 139 | 6 | 650095a17e1a39caea74a6e89646565b9332af5d | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-05 | 177 | 139 | 6 | d1af0cb4b1fb03f04cff5add85e29be8fb8f4dcb | |
| ToppCell | BAL-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 2.11e-05 | 179 | 139 | 6 | 68511e87b12b8253de7771e5ccfc5869248b8450 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 2.78e-05 | 188 | 139 | 6 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.78e-05 | 188 | 139 | 6 | d9692b6048d9b85524a07a1807bdd4757731c151 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.87e-05 | 189 | 139 | 6 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | COVID-19_Mild-Treg|COVID-19_Mild / Disease condition and Cell class | 2.87e-05 | 189 | 139 | 6 | f0fceb5f87ca260bfe038c0db3487a6d2e1b0a6e | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.95e-05 | 190 | 139 | 6 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-05 | 191 | 139 | 6 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.04e-05 | 191 | 139 | 6 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-05 | 191 | 139 | 6 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-IPC_like|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.04e-05 | 191 | 139 | 6 | 48cffb55c71bb8b34e926fc461fcd345ce43ea00 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-IPC_like-IPCs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.04e-05 | 191 | 139 | 6 | e4c1c533771b582e21683dbec6f93a558d865e00 | |
| ToppCell | Substantia_nigra|World / BrainAtlas - Mouse McCarroll V32 | 3.06e-05 | 115 | 139 | 5 | 18174b8d57d444fab1e9d2b13d22939c83c958e0 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.13e-05 | 192 | 139 | 6 | 7a90ec9fc8f29216c4828e0cf5d040906456e53b | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.13e-05 | 192 | 139 | 6 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.13e-05 | 192 | 139 | 6 | d883b91bbab71673de4858346d3ab33e5fbbf842 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.13e-05 | 192 | 139 | 6 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.13e-05 | 192 | 139 | 6 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.13e-05 | 192 | 139 | 6 | 0afb9dbe468e0be442c326e11c5fc0f699b32f23 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.22e-05 | 193 | 139 | 6 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-IPC_like-IPCs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.22e-05 | 193 | 139 | 6 | 2088f1d210c73f74685492c63065c62ac3f553e9 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-IPC_like|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.22e-05 | 193 | 139 | 6 | f24bae40f5cbcfece04fbefe4e3de1b88ac90de4 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam_____kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 193 | 139 | 6 | b397c14ac1e34c6be3f25d4417d200bc518d3048 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 193 | 139 | 6 | 241a60d1f0d5832638fb3e1e4b7afa7387ea3c75 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-05 | 194 | 139 | 6 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | Mild/Remission-B_naive-8|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.42e-05 | 195 | 139 | 6 | 0a3221e4d1fa31a35868bdda0f0cc873c233b407 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-IPC_like-IPCs/Immature_PNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.42e-05 | 195 | 139 | 6 | 5e36a881fe2646f5a95d07d7b9265e6ada38730c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.42e-05 | 195 | 139 | 6 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 3.52e-05 | 196 | 139 | 6 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-05 | 196 | 139 | 6 | f40d10ea7714067585493fdc89744714aa427de8 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-midbrain/hindbrain_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 3.52e-05 | 196 | 139 | 6 | 0767581b69bc7e6334d580ca02ed1e831b7b55da | |
| ToppCell | facs-Brain_Non-Myeloid|facs / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 197 | 139 | 6 | a1f7eec1aca03432caa8fe817ff6d24b29d4062d | |
| ToppCell | 390C-Myeloid-Monocyte-CD16+_Monocyte|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.62e-05 | 197 | 139 | 6 | 01f5f5c34e904cc0146e978cc05ed1cd86a41533 | |
| ToppCell | mild-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.62e-05 | 197 | 139 | 6 | 39800e6e83f2d333b753d121c7aeb2912b91faa2 | |
| ToppCell | severe-Treg|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.72e-05 | 198 | 139 | 6 | 377980b9f7d02818e1d145e6884604f8bfacc4f2 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.72e-05 | 198 | 139 | 6 | db107a5511571384f26e26c6301aef9a9f2423c4 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 3.72e-05 | 198 | 139 | 6 | 8689090bce9ab6e8f122426a404037e572c6713b | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 199 | 139 | 6 | 565404c155dfac57c020a8f2d09cbf756da20ffd | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.83e-05 | 199 | 139 | 6 | a900ef002e1ae583b70be0253d8c44dae6754916 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 199 | 139 | 6 | f894c88ecc7fd0edca28587801fa59352d10f750 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 199 | 139 | 6 | 6c174dbcc25b980f10a3d1dfe39e613acac73bb6 | |
| ToppCell | BAL-Control-cDC_0|Control / Compartment, Disease Groups and Clusters | 3.83e-05 | 199 | 139 | 6 | 4518ffa51ead9da1ddf07bf048b18602e50f0f84 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.83e-05 | 199 | 139 | 6 | fff88d2bba262583bb726900ae01e44954b72eb9 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 199 | 139 | 6 | 284ee9632413f6404fc0b0c7c393ad813db834f2 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.83e-05 | 199 | 139 | 6 | 6a2943a23fdd2ec814662db7c21a0d6804a6cbbc | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.83e-05 | 199 | 139 | 6 | 67f78c070c56e44fba36542041bf7fa1c291807c | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.83e-05 | 199 | 139 | 6 | 1ae244b563f85c1ee8d22698f478c842a4d9c7f5 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 199 | 139 | 6 | 2b754670fe77c2301afcdcfc73a1e52cc0cd1de3 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-Treg|Bac-SEP / Disease, condition lineage and cell class | 3.83e-05 | 199 | 139 | 6 | e0b6136e28b813299b7ffbe37f1cf830e60cd7d8 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-Treg|COVID-19_Severe / Disease, condition lineage and cell class | 3.93e-05 | 200 | 139 | 6 | 2b363f2a1d08019b6ff0b10419870049063cc1cf | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary|LPS_only / Treatment groups by lineage, cell group, cell type | 3.93e-05 | 200 | 139 | 6 | ce8281c9556a1f64f8ca8a029110077d4ef5b35e | |
| ToppCell | mild-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.93e-05 | 200 | 139 | 6 | fe815824e9e4be3f3db73610e3814a7fd533da65 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.93e-05 | 200 | 139 | 6 | f99e214eb680fd82a33f2b1524fbfca265d1cc42 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.93e-05 | 200 | 139 | 6 | d85074b362b11e5a523a5325d203a61aa2759a7a | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_only / Treatment groups by lineage, cell group, cell type | 3.93e-05 | 200 | 139 | 6 | 83c4181c083b364f0d3a89ae7a0504781fa9fa9f | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_only / Treatment groups by lineage, cell group, cell type | 3.93e-05 | 200 | 139 | 6 | f15baf287ec467664c23faa53fdea45257f7b9d0 | |
| ToppCell | (61)_LYVE1_Macrophage|World / shred on Cell_type and subtype | 4.64e-05 | 206 | 139 | 6 | 711e961a9a03bfd2f0958bd14f25f7f207a2f2b5 | |
| ToppCell | (2)_MNPs-(2)_Mono_macro|(2)_MNPs / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 4.80e-05 | 64 | 139 | 4 | 494f500ccceeedf45b4ded919b237a7fb75827c4 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.36e-05 | 142 | 139 | 5 | 4ac3b285adfe80c47861943cf8c6188106cb3ba8 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Neuroendocrine_Carcinoma-2|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 9.53e-05 | 146 | 139 | 5 | bc2adef529d0bbfcccef7435401a47a6ffcc1832 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Neuroendocrine_Carcinoma|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 9.53e-05 | 146 | 139 | 5 | 72c1e7e0c2b6ff6c4084af61fa19c2b8eab16eda | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.05e-04 | 149 | 139 | 5 | a85a051e0d82430160967e72fa04b55f43e84513 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-04 | 149 | 139 | 5 | 3e05711ad4a8c2e6ebe6f36b1cef8b17ec2a1708 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.08e-04 | 150 | 139 | 5 | 7a381f5ae94eba5eb60dcbf83416b4eb18c279ea | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Unc5b_(Neuron.Gad1Gad2.Pvalb-Unc5b)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.10e-04 | 79 | 139 | 4 | cc17a013a4a57a99c404b10449ef61ce559631d1 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Unc5b_(Neuron.Gad1Gad2.Pvalb-Unc5b)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.10e-04 | 79 | 139 | 4 | 19fb2bc964589ea40e7b9f0809c641331c93dacd | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.12e-04 | 151 | 139 | 5 | 28e3f77d2edb30fcf1414762a55ceffaf879d526 | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.12e-04 | 151 | 139 | 5 | 688cc5e4d46ba16f9b431352d7a6d39b21941e9c | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.12e-04 | 151 | 139 | 5 | 45392bb1c6358beff33da0ca84f7696fb5824f30 | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.12e-04 | 151 | 139 | 5 | 3d861285c71abe220b19a069eb9876199c6c8f39 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.19e-04 | 153 | 139 | 5 | ee6f4770c6e35d59bdeec5b0ecb10119fa8c3ca5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.19e-04 | 153 | 139 | 5 | a35149a0c8b4ec9ad27cc4b3d34fba3b8714a6a2 | |
| Drug | Azaperone [1649-18-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 3.54e-07 | 197 | 138 | 10 | 7231_DN | |
| Drug | Sotalol hydrochloride [959-24-0]; Up 200; 13uM; MCF7; HT_HG-U133A | 3.18e-06 | 196 | 138 | 9 | 7338_UP | |
| Drug | sodium 4-phenylbutyrate; Down 200; 1000uM; HL60; HG-U133A | 3.75e-06 | 200 | 138 | 9 | 411_DN | |
| Drug | Equilin [474-86-2]; Up 200; 15uM; MCF7; HT_HG-U133A | 2.30e-05 | 192 | 138 | 8 | 5620_UP | |
| Drug | Mefenamic acid [61-68-7]; Down 200; 16.6uM; PC3; HT_HG-U133A | 2.57e-05 | 195 | 138 | 8 | 5109_DN | |
| Drug | 1uyf | 2.69e-05 | 58 | 138 | 5 | CID000448972 | |
| Drug | Streptomycin sulfate [3810-74-0]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 2.77e-05 | 197 | 138 | 8 | 3195_DN | |
| Drug | Alfaxalone [23930-19-0]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.87e-05 | 198 | 138 | 8 | 5451_DN | |
| Drug | Tolnaftate [2398-96-1]; Down 200; 13uM; MCF7; HT_HG-U133A | 2.87e-05 | 198 | 138 | 8 | 4805_DN | |
| Drug | Oxybenzone [131-57-7]; Up 200; 17.6uM; MCF7; HT_HG-U133A | 2.98e-05 | 199 | 138 | 8 | 6469_UP | |
| Drug | Levamisole hydrochloride [16595-80-5]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 2.98e-05 | 199 | 138 | 8 | 2257_DN | |
| Drug | sodium 4-phenylbutyrate; Up 200; 1000uM; MCF7; HG-U133A | 2.98e-05 | 199 | 138 | 8 | 408_UP | |
| Drug | Ald1.1-H_000455; Up 200; 10uM; MCF7; HT_HG-U133A | 2.98e-05 | 199 | 138 | 8 | 7516_UP | |
| Drug | Pyrimethamine [58-14-0]; Up 200; 16uM; MCF7; HT_HG-U133A | 3.08e-05 | 200 | 138 | 8 | 1474_UP | |
| Disease | monocyte count | ASXL1 DENND4A CEBPB ANK1 HBP1 R3HDM2 PLEKHA6 SSBP3 MAST2 WNK1 DENND2B AHDC1 CIC TFDP2 HIVEP3 KIF3B NFIA VCAN MAST1 DMRTA1 SSBP4 | 7.07e-07 | 1320 | 136 | 21 | EFO_0005091 |
| Disease | cerebral palsy (implicated_via_orthology) | 1.12e-05 | 10 | 136 | 3 | DOID:1969 (implicated_via_orthology) | |
| Disease | interleukin-6 measurement, response to cytokine | 2.11e-05 | 2 | 136 | 2 | EFO_0004810, GO_0034097 | |
| Disease | interleukin-6 measurement, response to corticosteroid, response to cytokine | 2.11e-05 | 2 | 136 | 2 | EFO_0004810, GO_0031960, GO_0034097 | |
| Disease | obsolete_red blood cell distribution width | MOK ASXL1 ANK1 TTC28 R3HDM2 RGP1 WNK1 DENND2B CYRIB MAST4 GAREM2 MAST1 USP4 DMRTA1 SSBP4 AGAP7P SPSB2 MAST3 | 4.88e-05 | 1347 | 136 | 18 | EFO_0005192 |
| Disease | Hypermetropia | 1.18e-04 | 103 | 136 | 5 | HP_0000540 | |
| Disease | physical activity measurement | 1.47e-04 | 245 | 136 | 7 | EFO_0008002 | |
| Disease | cortical surface area measurement | CELF5 ZNF474 SSBP3 MAST2 RGP1 ADGRA2 RFX4 TFAP2B TFDP2 MAST4 NFIA VCAN C6orf15 NAV2 DMRTA1 RPS6KL1 SMAD5 | 1.57e-04 | 1345 | 136 | 17 | EFO_0010736 |
| Disease | prostate carcinoma | DAB2IP ZBTB20 TTC28 SSBP3 MAST2 EZHIP SLC2A4RG MAST4 DPEP2 C6orf15 AGAP7P RPS6KL1 CRTC2 | 2.53e-04 | 891 | 136 | 13 | EFO_0001663 |
| Disease | neuroimaging measurement, brain volume measurement | 3.76e-04 | 286 | 136 | 7 | EFO_0004346, EFO_0006930 | |
| Disease | brain volume measurement | 4.52e-04 | 595 | 136 | 10 | EFO_0006930 | |
| Disease | cortical thickness | CELF5 EYA4 ZNF474 SSBP3 MAST2 ADGRA2 RFX4 TFDP2 VPS13D MAST4 NFIA VCAN NAV2 DMRTA1 | 6.44e-04 | 1113 | 136 | 14 | EFO_0004840 |
| Disease | Parkinson disease | 7.45e-04 | 321 | 136 | 7 | MONDO_0005180 | |
| Disease | left ventricular structural measurement | 7.46e-04 | 88 | 136 | 4 | EFO_0008205 | |
| Disease | dentate gyrus volume measurement | 7.75e-04 | 39 | 136 | 3 | EFO_0010083 | |
| Disease | eye color | 8.12e-04 | 90 | 136 | 4 | EFO_0003949 | |
| Disease | hematocrit | RANBP10 ZBTB20 R3HDM2 SYNPO SNX33 PLEKHA6 MAST2 DENND2B TFAP2B PRR12 NFIA ARID2 ANKRD17 | 8.26e-04 | 1011 | 136 | 13 | EFO_0004348 |
| Disease | hippocampal CA4 volume | 8.98e-04 | 41 | 136 | 3 | EFO_0009396 | |
| Disease | dilated cardiomyopathy (is_implicated_in) | 1.03e-03 | 43 | 136 | 3 | DOID:12930 (is_implicated_in) | |
| Disease | selective IgA deficiency disease | 1.26e-03 | 46 | 136 | 3 | EFO_1001929 | |
| Disease | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1.35e-03 | 12 | 136 | 2 | C0023485 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 1.59e-03 | 13 | 136 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 2.13e-03 | 15 | 136 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | PR interval | 2.15e-03 | 495 | 136 | 8 | EFO_0004462 | |
| Disease | response to triptolide, cytotoxicity measurement | 2.43e-03 | 16 | 136 | 2 | EFO_0006952, EFO_0007662 | |
| Disease | cognitive function measurement | DENND4A TTC28 NRL FIGN ADGRA2 TFAP2B TFDP2 MST1R PRR12 MAST4 PLAA TULP4 NFIA MAST1 RAB11FIP5 | 2.58e-03 | 1434 | 136 | 15 | EFO_0008354 |
| Disease | esophageal carcinoma, gastric carcinoma | 2.74e-03 | 17 | 136 | 2 | EFO_0000178, EFO_0002916 | |
| Disease | comparative body size at age 10, self-reported | 3.42e-03 | 420 | 136 | 7 | EFO_0009819 | |
| Disease | p-tau:beta-amyloid 1-42 ratio measurement | 3.43e-03 | 19 | 136 | 2 | EFO_0007709 | |
| Disease | coronary artery disease | DAB2IP SORBS2 ZBTB20 R3HDM2 FIGN SPATA2 DENND2B AHDC1 TFAP2B MAST4 NFIA PAX5 DNASE1L1 | 3.56e-03 | 1194 | 136 | 13 | EFO_0001645 |
| Disease | hearing loss | 3.70e-03 | 67 | 136 | 3 | EFO_0004238 | |
| Disease | seborrheic dermatitis | 3.79e-03 | 20 | 136 | 2 | EFO_1000764 | |
| Disease | brain measurement, neuroimaging measurement | 4.07e-03 | 550 | 136 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | cortical surface area measurement, neuroimaging measurement | 4.11e-03 | 227 | 136 | 5 | EFO_0004346, EFO_0010736 | |
| Disease | Precursor B-cell lymphoblastic leukemia | 4.18e-03 | 21 | 136 | 2 | C1292769 | |
| Disease | HIV-1 infection, Susceptibility to viral and mycobacterial infections | 4.18e-03 | 21 | 136 | 2 | EFO_0000180, Orphanet_391311 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GSLNNYSSSIPSTPS | 186 | Q96P64 | |
| RLLGSSASSPGYQSS | 436 | Q9P2B4 | |
| SGPESGRSSPYHSQL | 401 | O94929 | |
| PFQALSPSAGSSYAG | 966 | A0A096LP49 | |
| SPSAGSSYAGPATLH | 971 | A0A096LP49 | |
| SSQTPSSPLTIYSGS | 2821 | P13611 | |
| PTDSYLGSSRNSPGA | 1226 | Q96PE1 | |
| PTASTVNSPSYLNSG | 401 | Q9H175 | |
| YSILSESTPGSLSGT | 1386 | P16157 | |
| TTLKSYDSNTPGPAG | 341 | Q14956 | |
| PTASGSSVSPGLYSK | 171 | Q9BQL6 | |
| LPKSATSPAGSSSAY | 676 | A8MVX0 | |
| GRKYSDSSLPPSNSG | 1296 | Q68CP9 | |
| SGSTGSSLHTPYQPL | 371 | Q8IV13 | |
| SVTSAYSSAPDGSPP | 851 | O94983 | |
| TLSQGSPSYGSPEDT | 226 | O00213 | |
| AYGSGNSLPASPSSA | 1001 | Q5TGY3 | |
| DSPYGSVTPSSTHLG | 2326 | O75179 | |
| SSLQSLYPSSPTENG | 456 | P78524 | |
| SLTSTYTNTPAGSPL | 436 | Q96BY7 | |
| YSSSSPTFPKGLAGS | 1456 | Q8IXJ9 | |
| GSLNNYSSSIPSTPS | 186 | Q5VW22 | |
| SQLGSVSQGPYSSAP | 41 | Q92481 | |
| LSSPATSSPSGNAYS | 616 | Q9HBZ2 | |
| GPITTATSLYSSDPS | 801 | Q5JR59 | |
| QSTPYGRPANISGST | 121 | Q7Z401 | |
| TSTEGGAASPTSPTY | 461 | Q12857 | |
| GAASPTSPTYSTPST | 466 | Q12857 | |
| STGQPLPTSNYSTSS | 481 | Q9Y2K5 | |
| LSSRSPKSQDSYPGS | 351 | Q6VN20 | |
| GSPTSYFTSGLQAGL | 486 | Q8IY67 | |
| SPSSQSAAASSLGPY | 291 | Q96PK6 | |
| VSNPSPEYTGLSTTG | 531 | Q33E94 | |
| STLSSASGSLAYQGP | 256 | Q9BXF6 | |
| GSSYSISGILGITSP | 176 | Q02548 | |
| PQLSPSLSQSTYTTG | 971 | Q7Z6G8 | |
| LSPGSSAYPSATVLS | 351 | O15528 | |
| SSGVQPSPARSSSYS | 716 | Q5VWQ8 | |
| SVTSPSPLYSTPSGS | 9441 | Q8WXI7 | |
| SPLYSTPSGSSHSSP | 9446 | Q8WXI7 | |
| PPSYSTAKNSLGSRS | 401 | Q5HY92 | |
| GRNSLSSLPTYSTGG | 221 | Q9BRK4 | |
| SSLPTYSTGGAEPTT | 226 | Q9BRK4 | |
| SLYSPVSQAGSLSPA | 171 | Q9Y4Z2 | |
| APQISYTGPSSSGRF | 266 | O43639 | |
| SYGVTPPSLSHSGNR | 871 | Q14703 | |
| PSALQTGGSAAPSSY | 386 | O95835 | |
| PSSYPCSGASTSSQA | 181 | Q86X51 | |
| TASLGSTPYSSVPPS | 36 | P54845 | |
| SLTSSQYSLTGGSPG | 106 | Q96LR2 | |
| SSATVTGEPPSYSSG | 491 | P35658 | |
| SYSSGSDSSKAAPGP | 501 | P35658 | |
| SPPFSSLSVNGGASY | 376 | P48742 | |
| GPQRLSGSSYGSISS | 6 | P49279 | |
| SSYSSPTLQSVLGSG | 361 | Q9UQ07 | |
| YTNPGSSLVSPSLAA | 156 | Q02078 | |
| SYISAASPAPSTGFG | 331 | O43347 | |
| LASLPSSGYGTNTPS | 91 | Q9Y2H9 | |
| QASGVPSPYLSSLAS | 121 | Q8NBZ0 | |
| PQSSSPVYGSSAKTS | 81 | P49023 | |
| SLTGAYASGIPSSSR | 396 | Q96HA1 | |
| YIGSSGSSPSRTSPE | 16 | P20393 | |
| SSSFYNGSPPGSLQV | 91 | P20393 | |
| SYLSSAAALAPGSGP | 136 | Q6UXA7 | |
| TGSPLNSAAYSSPKL | 176 | P15976 | |
| SVYPPASSSSLSGGH | 131 | P23771 | |
| TQSPLQSGCLSYSPG | 211 | O95677 | |
| SGGLASPSSSESHPY | 616 | A4D2P6 | |
| SLGYLSSLSSSQPPE | 226 | A6NFR6 | |
| FDGSGPYSTLSSPQL | 76 | P49184 | |
| LISNSPVLSGSYSSG | 1836 | Q8N1I0 | |
| PVLSGSYSSGISSLS | 1841 | Q8N1I0 | |
| PQSSLLYSISTGGAS | 491 | Q6ZTQ4 | |
| TAYPSLSGGNSTSNL | 296 | Q53ET0 | |
| LGYQAVPSGSSGSLS | 211 | P17676 | |
| PLQTTSASYGGDSSL | 411 | Q5VZB9 | |
| TSGSYLSPGVAFSPC | 261 | Q8N6W0 | |
| GSLNNYSSSIPSTPS | 186 | Q5VUJ5 | |
| LASLPSSGYGTNTPS | 231 | Q6P0Q8 | |
| LASLPSSGYGTNTPS | 86 | O60307 | |
| LASLPSSGYGTNTPS | 286 | O15021 | |
| GTYAPSTTLSSPSTQ | 56 | Q9H4A9 | |
| GSPGSSQLSSNSLYA | 401 | O60381 | |
| GLLGALTSTPYSPTQ | 106 | Q9NUQ9 | |
| PSSNGISSSLPLFYS | 156 | Q8NDH2 | |
| PTYSLASPTLGGATS | 136 | Q8N813 | |
| AISSSYSSTGGLPGL | 121 | Q3SYA9 | |
| SGPVIPVYTSNSGTS | 241 | Q14469 | |
| SQAPGLSPSGKTTDY | 31 | Q8IWW8 | |
| SRSGSGSPSPDTYSL | 536 | Q75VX8 | |
| PPSASAALNSGASYI | 271 | Q12946 | |
| NSANSIPYSSSSPGT | 251 | Q9BWW4 | |
| PGLMSPSSGYSSQSE | 706 | Q5HYW2 | |
| YSSSGTPSSASPALS | 271 | Q14934 | |
| LASYAAPGPSTSTIT | 376 | Q92546 | |
| SRSSPGLYTSPGQDS | 861 | Q8N3V7 | |
| GSGVLSSGSSSPLYS | 1366 | Q8IVL1 | |
| SSSPAGSPGAQVSLY | 71 | Q8WV41 | |
| GSDGSLSASPLFYSP | 501 | Q5T8A7 | |
| DPSSSSSSGNPLVYL | 36 | P30405 | |
| SQGLPTASPSLSYST | 521 | Q9ULL5 | |
| QSSQGTPYTSRGSTP | 266 | O15047 | |
| PSLCSYSGLNGNPSS | 316 | O94875 | |
| TSSGSVLIGSPYTPA | 71 | Q14188 | |
| LCSLSPGGLSYSPSQ | 71 | Q6PIS1 | |
| PGGLSYSPSQLLASS | 76 | Q6PIS1 | |
| SPASSTYPNSPASSG | 196 | Q99717 | |
| SSLFSGSYSSLSPNP | 146 | Q13490 | |
| KGYGSAPSSSASSPA | 526 | Q96RK0 | |
| PASSQAGTVTSYGPT | 1021 | Q96RK0 | |
| GPGYGISQSSRLSSS | 571 | O75122 | |
| YPSTDLSGASSSSLP | 6 | P48995 | |
| QNTYTLPGPGSSATL | 911 | Q9NRJ4 | |
| GPSATYSSNSPASPL | 681 | Q9Y2H5 | |
| SPSNGPALLRGTYFS | 316 | Q9UM82 | |
| SSSLHGISLPTAYPG | 3041 | Q86UP3 | |
| PSSTSSASALYGQPL | 591 | Q13107 | |
| IPSETYSSSPSGAGS | 461 | P40200 | |
| PSQPLSSIDGYGSSM | 611 | Q6ZNA4 | |
| QASSGYASLLSSPPT | 806 | O15027 | |
| LVRPPGSYSSSSNSG | 141 | Q9NR83 | |
| SSSSSGTPASQLYPQ | 726 | O15066 | |
| YSSGLGSQTSLQPPA | 456 | Q9BSA4 | |
| SSSVYPASAGTSLGI | 316 | Q6NTF9 | |
| PSGNSIPYSSSSPGS | 246 | Q9BWG4 | |
| LGSFTYSTSAPGPAL | 231 | Q7L0R7 | |
| LAGGSSSTPTPQALY | 6 | Q99619 | |
| RYVPGSSGSSNTLPT | 476 | Q9Y263 | |
| VSSSVPYPGSGTAAT | 31 | Q5T1R4 | |
| LLGSEVGQPYSSSSP | 106 | A0A1W2PR48 | |
| SSTPSSRPASLGYSG | 246 | Q96S82 | |
| QPITYGPSHSGSATT | 911 | Q12968 | |
| SLGFLGTTLSLPPYS | 251 | C9JH25 | |
| GSSPSLPASGSYQAL | 841 | C9JH25 | |
| PLSSGASPSAGFSSL | 121 | Q9Y6S9 | |
| TVSSSSYGSQPPGPS | 1276 | Q68DE3 | |
| SAPSSSGSPLYEGAA | 391 | O15178 | |
| SGYLFSGSRPPSQVS | 466 | Q5SNT2 | |
| SAPGSTVTTQLGPYA | 841 | Q8IZJ1 | |
| GQSVLSYSPSRSPST | 136 | Q96SK2 | |
| TYLPALFTTQPAGSG | 506 | Q9HC78 | |
| PGTDKLLSGYPSSSS | 546 | Q96F45 | |
| AGSAPSPALSYSSAG | 2316 | Q96AY4 | |
| PSKPQSLSSSGSYSL | 136 | Q6S9Z5 | |
| APSSSSSPGAGVSSY | 1546 | Q9H4A3 | |
| TAASLTSPRSGNPGY | 371 | Q6NUS6 | |
| QTAGATPLPILYSGS | 1001 | Q04912 | |
| PPAFYSTSSGLANGL | 166 | O95231 | |
| PPGTTSSNYSLGNFV | 221 | B6A8C7 | |
| TANPEGYISTLPGSS | 3426 | Q5THJ4 | |
| PSSGYSSQSGTPTLP | 521 | Q9P206 | |
| LSPGSTTASSLGPEY | 706 | Q9UKN1 |